Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal.
BACKGROUND
We have previously shown that gut microbial fermentation of prebiotics promotes satiety and lowers hunger and energy intake in humans. In rodents, these effects are associated with an increase in plasma gut peptide concentrations, which are involved in appetite regulation and glucose homeostasis.


OBJECTIVE
Our aim was to examine the effects of prebiotic supplementation on satiety and related hormones during a test meal for human volunteers by using a noninvasive micromethod for blood sampling to measure plasma gut peptide concentrations.


METHODS
This study was a randomized, double-blind, parallel, placebo-controlled trial. A total of 10 healthy adults (5 men and 5 women) were randomly assigned to groups that received either 16 g prebiotics/d or 16 g dextrin maltose/d for 2 wk. Meal tolerance tests were performed in the morning to measure the following: hydrogen breath test, satiety, glucose homeostasis, and related hormone response.


RESULTS
We show that the prebiotic treatment increased breath-hydrogen excretion (a marker of gut microbiota fermentation) by approximately 3-fold and lowered hunger rates. Prebiotics increased plasma glucagon-like peptide 1 and peptide YY concentrations, whereas postprandial plasma glucose responses decreased after the standardized meal. The areas under the curve for plasma glucagon-like peptide 1 and breath-hydrogen excretion measured after the meal (0-60 min) were significantly correlated (r = 0.85, P = 0.007). The glucose response was inversely correlated with the breath-hydrogen excretion areas under the curve (0-180 min; r = -0.73, P = 0.02).


CONCLUSIONS
Prebiotic supplementation was associated with an increase in plasma gut peptide concentrations (glucagon-like peptide 1 and peptide YY), which may contribute in part to changes in appetite sensation and glucose excursion responses after a meal in healthy subjects.
Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Université Catholique de Louvain, Brussels, Belgium. patrice.cani@uclouvain.be
Patrice D
PD
Cani
Elodie
E
Lecourt
Evelyne M
EM
Dewulf
Florence M
FM
Sohet
Barbara D
BD
Pachikian
Damien
D
Naslain
Fabienne
F
De Backer
Audrey M
AM
Neyrinck
Nathalie M
NM
Delzenne
D000328:Adult; D001066:Appetite / Q000187:drug effects / Q000502:physiology*; D001786:Blood Glucose / Q000378:metabolism; D001944:Breath Tests; D004043:Dietary Fiber / Q000494:pharmacology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D004435:Eating / Q000502:physiology*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000097:blood; D006801:Humans; D006859:Hydrogen / Q000032:analysis; D054795:Incretins / Q000096:biosynthesis*; D008297:Male; D010191:Pancreatic Polypeptide / Q000097:blood; D019894:Peptide YY / Q000097:blood; D012528:Satiety Response / Q000502:physiology*
D001786:Blood Glucose; D004043:Dietary Fiber; D054795:Incretins; D019894:Peptide YY; D010191:Pancreatic Polypeptide; D006859:Hydrogen; D052216:Glucagon-Like Peptide 1